BioGlow Health review
Wide menu, thin disclosure
A five-vertical telehealth brand running sermorelin and NAD⁺ beside TRT, ED, hair and weight loss — with no clinicians, pharmacy or peptide price published.
Our verdict
BioGlow Health is built for consolidation: peptides, testosterone, weight loss, ED and hair on one account, shipped to all 50 states, with a free consultation and free shipping. Convenience is the entire pitch. Nothing supporting it is disclosed — no prescribing clinicians, no compounding pharmacy, no peptide price — and its weight-loss menu sells retatrutide, an investigational molecule the FDA has not approved, which is a judgement signal that carries across the whole platform.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- All 50 states, free consultation and shipping; peptide pricing not published
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- All 50 states
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
BioGlow Health is a physician-supervised, multi-vertical direct-to-consumer telehealth brand covering weight loss, peptide therapy, TRT, hair loss and erectile dysfunction. Its peptide line lists sermorelin and NAD⁺ on the live site, with a wider set — BPC-157, CJC-1295, ipamorelin, GHK-Cu, selank and PT-141 — recorded in the site's own application bundle at verification. It ships compounded medication to all 50 states, cash-pay, with the consultation and shipping free. Its compounding pharmacies are described as 503A and are not named, and its governing law is stated as Florida.
How it works
An online intake reviewed by a provider before anything is prescribed, then compounded medication shipped nationwide. Free consultation and free shipping are real inclusions rather than upsells. Beyond that the model is opaque in ways that matter more for peptides than for a refill: the prescribing clinicians and medical group are not named, the 503A pharmacy is not named, no lab work sits in the default path before a growth-hormone-axis peptide, and the operating entity is disclosed only as "BioGlow Health" without a corporate suffix. At our live check the product catalogue itself failed to render, returning "no products found", so even the menu is not reliably readable without starting an intake. If you are stacking a peptide with the testosterone or GLP-1 line, ask explicitly how the protocols are coordinated and what monitoring is scheduled.
Pricing transparency
No peptide price is published, and we are not quoting one. BioGlow's weight-loss line does carry published monthly figures, but those are GLP-1 prices and say nothing about what sermorelin or NAD⁺ costs — and even there our record and the live site disagree on one of the rows, which is reason enough to treat any figure as a snapshot rather than a quote. The service is cash-pay with no insurance accepted. Ask for the monthly peptide price, whether it changes with dose, whether the free consultation and free shipping apply to the peptide line as well, and what refills cost.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The peptide and GLP-1 products are 503A compounding-pharmacy preparations, not therapeutically equivalent to branded drugs, and the pharmacy is not named. One item on the wider menu deserves to be flagged rather than buried: BioGlow sells retatrutide, an investigational molecule that has not completed the approval process and is not an approved medicine — selling it to consumers is a meaningful signal about where a platform draws its lines, and it is relevant to a reader evaluating its peptide line. On the peptide evidence itself, take the menu in tiers. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data. Injectable NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and they raise a biomarker rather than demonstrate an outcome. BPC-157, GHK-Cu and selank sit lower still, with essentially no controlled human outcome data at all. Individual results vary.
Pros and watch-outs
What we like
- Free consultation and free shipping, with compounded medication shipped to all 50 states
- One account covers peptides, testosterone, weight loss, ED and hair
- A provider reviews the online intake before anything is prescribed
- Peptide line includes sermorelin and NAD⁺ rather than GLP-1 add-ons only
- Governing law and a Florida jurisdiction are at least stated
Watch-outs
- No peptide price published anywhere, and the live catalogue failed to render at our check
- Prescribing clinicians and the 503A compounding pharmacy are both unnamed
- Sells retatrutide, an investigational molecule the FDA has not approved
- Operating entity only lightly disclosed, with no corporate suffix or address
- Cash-pay only, with no lab work before a growth-hormone-axis peptide
Best for
People who want peptides, testosterone and weight-loss care from a single nationwide account and are willing to start an intake to see any detail.
Who should look elsewhere
Anyone who wants a peptide price up front, a named prescriber or pharmacy, or a menu that stops at compounds with human outcome data.
The evidence behind what BioGlow Health prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- TRT: what testosterone therapy is actually proven to do
An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.
How BioGlow Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
Peter MD
GLP-1 from a men's-health provider that also covers TRT and longevity
See Peter MD →
Telos RXChoice of GLP-1 formats, including needle-free sublingual tirzepatide
See Telos RX →- System Labs
NAD⁺ bundled with glutathione, B-12 and sermorelin from one service
See System Labs →
Pharmacology & mechanisms · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of BioGlow Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What peptides does BioGlow Health offer?
- Sermorelin and NAD⁺ are listed under peptide therapy on the live site, and its own site bundle also recorded BPC-157, CJC-1295, ipamorelin, GHK-Cu, selank and PT-141. All are compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
- Why can't I see a peptide price?
- None is published, and at our live check the product catalogue returned "no products found" rather than a price list. Only the weight-loss line carries published monthly figures, and those are GLP-1 prices that tell you nothing about sermorelin or NAD⁺. Ask for the monthly peptide price and what it does at a higher dose.
- Should selling retatrutide change how I read this platform?
- It is worth weighing. Retatrutide is investigational and has not been approved by the FDA, so a consumer platform selling it is making a commercial choice about risk that a buyer is entitled to factor in — including when judging the peptide line, where BioGlow also names neither its prescribers nor its pharmacy.
- Does sermorelin do what it is marketed to do?
- Its effect on the growth-hormone axis is a genuine, well-described mechanism. What is missing is outcome data: no controlled human trial shows compounded sermorelin delivers the body-composition, recovery or anti-aging results it is sold for, and the long-term evidence stays thin.